Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Cell Impact | 22,347,500 | net | 20 Feb 2026 | tx 15+22,347,500 |
| Eros Capital Partners AB | 20,000 | net | 10 Nov 2022 | tx 1+20,000 |
| Arcam AB | -13,332 | net | 14 Nov 2016 | tx 1−13,332 |
| Sandvik AB | 0.189 | net | 08 May 2020 | tx 2+17,444.189−17,444 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 20 Feb 2026 | PURCHASE | Cell Impact | 2,852,500 | 0.13 SEK | |
| 27 Aug 2025 | PURCHASE | Cell Impact | 1,000,000 | 0.17 SEK | |
| 17 Jul 2025 | PURCHASE | Cell Impact | 10,000,000 | 0.02 SEK | |
| 10 Jul 2025 | PURCHASE | Cell Impact | 6,975,000 | 0.02 SEK | |
| 17 Sept 2024 | OTHER | Cell Impact | 100,000 | 0.00 SEK | deriv |
| 03 Sept 2024 | PURCHASE | Cell Impact | 500,000 | 0.25 SEK | |
| 08 Mar 2024 | PURCHASE | Cell Impact | 500,000 | 0.18 SEK | |
| 04 Dec 2023 | PURCHASE | Cell Impact | 50,000 | 2.00 SEK | |
| 25 Aug 2023 | PURCHASE | Cell Impact | 30,000 | 3.60 SEK | |
| 10 Nov 2022 | PURCHASE | Eros Capital Partners AB | 20,000 | 9.60 SEK | |
| 26 Sept 2022 | PURCHASE | Cell Impact | 40,000 | 2.22 SEK | derivfirst after silence |
| 08 May 2020 | SALE | Sandvik AB | 17,444 | 148.65 SEK | |
| 06 May 2020 | PURCHASE | Sandvik AB | 17,444.189 | 146.10 SEK | anomaly |
| 14 Nov 2016 | SALE | Arcam AB | 13,332 | 300.00 SEK |
1 purchase reported after at least 12 months of silence — most recent on 26 Sept 2022.